Riskpilot← Back to searchSign inGet full accessJOKAR MED AB
ABActiveOrg 5568279615Moränvägen 11General medical practice activities · NACE 8621Est. 20100 employees
Revenue 2024
SEK 365K
-66% vs 2023
EBITDA margin
-2.5%
-101% vs 2023
Equity ratio
28.6%
Financial strength
Net profit 2024
SEK -30K
-106% vs 2023
| Revenue | SEK 365K | -66% |
| EBITDA | SEK -9K | -101% |
| Net profit | SEK -30K | -106% |
| Total assets | SEK 1,6M | -15% |
| Equity | SEK 463K | -34% |
| Employees | 0 | — |
Legal name
JOKAR MED AB
Org number
5568279615
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 november 2010
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk verksamhet, spec kirurgi, sjukvård, undervisning och forskning. Kulturkonsult med huvudsaklig in- riktning på körverksamhet, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Moränvägen 11
Email
jokar@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 530 | 722 | 1 088 | 1 076 | 365 |
| Staff expenses | — | — | −129 | −16 | −3 |
| EBITDA | 309 | 412 | 633 | 754 | −9 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 309 | 412 | 633 | 754 | −9 |
| Net financials | −1 | −2 | −3 | −0 | −3 |
| Profit before tax | 225 | 303 | 463 | 623 | −13 |
| Tax | −54 | −67 | −104 | −133 | −17 |
| Net profit | 171 | 236 | 358 | 490 | −30 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 875 | 1 245 | 1 645 | 1 907 | 1 618 |
| Equity | 295 | 350 | 529 | 700 | 463 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 387 | 593 | 646 | 607 | 555 |
| Total debt | 387 | 593 | 646 | 607 | 555 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20202024
Equity ratio
28.6%
This company
38.2%
Market median
-25% vs market
20202024
Return on equity
-6.5%
This company
18.4%
Market median
-135% vs market
20202024
Net profit margin
-8.2%
This company
8.1%
Market median
-201% vs market
20202024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
2.49×
This company
0.62×
Market median
-302% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JOKAR MED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bror Göran Ögren | Deputy Board Member | 0 companies |
| Lars Niklas Karlsson | Deputy Board Member | 0 companies |
| Maud Ingeborg Behmer | Deputy Board Member | 0 companies |
| Johnny Lars-Göran Karlsson | Board of Directors | 0 companies |
| Stellan Tage Behmer | Deputy Board Member | 0 companies |
| Malin Kristina Backlund | Deputy Board Member | 0 companies |
| Monika Margareta Karlsson | Deputy Board Member | 0 companies |